These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2679683)

  • 21. Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Shungu DL; Ponticas S; Gill CJ
    Clin Ther; 1989; 11(3):315-8. PubMed ID: 2663161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity against clinically important gram-positive and gram-negative bacteria of sulbactam, alone and in combination with ampicillin, cefotaxime, mezlocillin, and piperacillin.
    Schmalreck AF; Wildfeuer A
    Arzneimittelforschung; 1990 Oct; 40(10):1145-55. PubMed ID: 2291754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
    Wexler HM; Harris B; Carter WT; Finegold SM
    Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
    Cáceres M; Carera E; Palmgren AC; Nord CE
    Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cefoxitin, cefotetan and the combination of ampicillin with sulbactam in the therapy of polymicrobial infection in mice.
    Brook I
    J Antimicrob Chemother; 1994 Nov; 34(5):791-6. PubMed ID: 7706175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of sulbactam/ampicillin against ampicillin-resistant, beta-lactamase-producing bacteria isolated in Italian hospitals.
    Varaldo PE; Ripa S; Nicoletti G; Covelli I; Satta G; Carlone N; Fontana R
    Chemotherapy; 1990; 36(2):141-6. PubMed ID: 2178890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of antibacterial agents against clinical isolates of Escherichia coli and Klebsiella species from intensive care units.
    Gill CJ; Ponticas S; Shungu DL; Guerriero S
    Clin Ther; 1991; 13(1):25-37. PubMed ID: 2029725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of cefotaxime alone and in combination with desacetylcefotaxime against Bacteroides fragilis.
    Wasilauskas BL
    Diagn Microbiol Infect Dis; 1989; 12(1):39-43. PubMed ID: 2714071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Fuchs PC; Barry AL; Jones RN
    J Clin Microbiol; 1988 Jun; 26(6):1246-7. PubMed ID: 3384939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of a combination of ampicillin and sulbactam against clinical isolates of anaerobic bacteria.
    Werner H; Heizmann W; Heilmann F
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S27-30. PubMed ID: 18611716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB; Ayers OM; Everett BQ
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
    Henderson G; Garner J; Morris A
    N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of clinical isolates of Haemophilus influenzae to ampicillin-sulbactam.
    Mortensen JE; LaRocco M; Himes SL; Inderlied C; Daly JA; Campos JM; Mendelman PM
    Diagn Microbiol Infect Dis; 1990; 13(4):341-4. PubMed ID: 2076596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
    King A; Phillips I
    J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
    Watanabe K; Kato N; Tanaka-Bandoh K; Tanaka Y; Kato H; Ueno K
    Jpn J Antibiot; 1996 Apr; 49(4):367-76. PubMed ID: 8786627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.